Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 8/20 | 0.50 |
| ▸ | KCNH2 | Q12809 | 5/20 | 0.50 |
| ▸ | CHRM2 | P08172 | 4/20 | 0.50 |
| ▸ | ADRA2A | P08913 | 4/20 | 0.50 |
| ▸ | DRD1 | P21728 | 4/20 | 0.50 |
| ▸ | SLC6A4 | P31645 | 4/20 | 0.50 |
| ▸ | SLC6A3 | Q01959 | 4/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.50 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.50 |
| ▸ | HTR2A | P28223 | 3/20 | 0.50 |
| ▸ | HRH1 | P35367 | 3/20 | 0.50 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.50 |
| ▸ | ADRA2B | P18089 | 2/20 | 0.50 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.50 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.49 |
| ▸ | LMNA | P02545 | 3/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3226743 | 0.94 | KCNH2 (0.49) | CYP2D6KCNH2CHRM2ADRA2ADRD1 | |
| SCHEMBL9812726 | 0.93 | KCNH2 (0.47) | CYP2D6KCNH2CHRM2ADRA2ADRD1 | |
| SCHEMBL5677763 | 0.92 | KCNH2 (0.44) | CYP2D6KCNH2CHRM2ADRA2ADRD1 | |
| SCHEMBL10651317 | 0.92 | KCNH2 (0.44) | CYP2D6KCNH2CHRM2ADRA2ADRD1 | |
| SCHEMBL10654586 | 0.90 | HRH1 (0.43) | CYP2D6KCNH2CHRM2ADRA2ADRD1 | |
| SCHEMBL6446263 | 0.88 | CYP2D6 (0.53) | CYP2D6KCNH2CHRM2ADRA2ADRD1 | |
| SCHEMBL16491446 | 0.85 | CHRM2 (0.60) | CYP2D6KCNH2CHRM2ADRA2ADRD1 | |
| SCHEMBL16491470 | 0.85 | CHRM2 (0.60) | CYP2D6KCNH2CHRM2ADRA2ADRD1 | |
| SCHEMBL16491448 | 0.85 | CHRM2 (0.60) | CYP2D6KCNH2CHRM2ADRA2ADRD1 | |
| SCHEMBL16491456 | 0.85 | CHRM2 (0.60) | CYP2D6KCNH2CHRM2ADRA2ADRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7442800-B2 | Nucleophilic heterocyclic carbene derivatives of Pd(acac)2 for cross-coupling reactions | PROMERUS LLC (US) | 2008-10-28 | — | — | US | claimed |
| CN-101184711-A | Nucleophilic heterocyclic carbene derivatives of pd(acac)2 for cross-coupling reactions | PROMERUS LLC (US) | 2008-05-21 | — | — | CN | claimed |
| EP-1885669-A1 | NUCLEOPHILIC HETEROCYCLIC CARBENE DERIVATIVES OF PD(ACAC)2 FOR CROSS-COUPLING REACTIONS | Promerus LLC (US) | 2008-02-13 | — | — | EP | claimed |
| US-20060287544-A1 | Nucleophilic heterocyclic carbene derivatives of Pd(acac)2 for cross-coupling reactions | PROMERUS LLC (US) | 2006-12-21 | — | — | US | claimed |
| WO-2006128097-A1 | NUCLEOPHILIC HETEROCYCLIC CARBENE DERIVATIVES OF PD(ACAC)2 FOR CROSS-COUPLING REACTIONS | PROMERUS LLC (US) | 2006-11-30 | — | — | WO | claimed |
| EP-0126950-B1 | METHOD FOR MAKING AROMATIC ETHERS AND CATALYST USED IN SUCH METHOD | GENERAL ELECTRIC COMPANY (US) | 1991-07-31 | — | — | EP | claimed |
| US-4472564-A | Method for making an enoxy stabilized room temperature vulcanizable organopolysiloxane composition which resists color change upon aging | GENERAL ELECTRIC COMPANY (US) | 1984-09-18 | — | — | US | claimed |
| US-7541462-B2 | Triaminophosphine ligands for carbon-nitrogen and carbon-carbon bond formation | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2009-06-02 | — | — | US | disclosed |
| US-7541462-B2 | Triaminophosphine ligands for carbon-nitrogen and carbon-carbon bond formation | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2009-06-02 | — | — | US | disclosed |
| US-7442800-B2 | Nucleophilic heterocyclic carbene derivatives of Pd(acac)2 for cross-coupling reactions | PROMERUS LLC (US) | 2008-10-28 | — | — | US | disclosed |
| US-7442800-B2 | Nucleophilic heterocyclic carbene derivatives of Pd(acac)2 for cross-coupling reactions | PROMERUS LLC (US) | 2008-10-28 | — | — | US | disclosed |
| US-7442800-B2 | Nucleophilic heterocyclic carbene derivatives of Pd(acac)2 for cross-coupling reactions | PROMERUS LLC (US) | 2008-10-28 | — | — | US | disclosed |
| US-20080139806-A1 | TRIAMINOPHOSPHINE LIGANDS FOR CARBON-NITROGEN AND CARBON-CARBON BOND FORMATION | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC.. | 2008-06-12 | — | — | US | disclosed |
| WO-1987004149-A1 | PHASE TRANSFER CATALYSTS | MALLINCKRODT, INC. (US) | 1987-07-16 | — | — | WO | disclosed |
| WO-1987004150-A1 | CATALYTIC METHOD FOR PRODUCING FLUOROAROMATIC COMPOUNDS USING SUBSTITUTED PYRIDINIUM SALTS | MALLINCKRODT, INC. (US) | 1987-07-16 | — | — | WO | disclosed |
| US-4472564-A | Method for making an enoxy stabilized room temperature vulcanizable organopolysiloxane composition which resists color change upon aging | GENERAL ELECTRIC COMPANY (US) | 1984-09-18 | — | — | US | disclosed |
| EP-0001965-B1 | PROCESS FOR THE PREPARATION OF FOAMED MATERIALS | BAYER AG (DE) | 1982-12-15 | — | — | EP | disclosed |
| US-4189542-A | Process for the production of foam moldings having an impervious outer skin using semi-prepolymer prepared from isocyanates such as isophorone diisocyanate | BAYER AKTIENGESELLSCHAFT (DE) | 1980-02-19 | — | — | US | disclosed |
| EP-0001965-A1 | Process for the preparation of foamed materials | BAYER AG (DE) | 1979-05-30 | — | — | EP | disclosed |
| US-4006124-A | POLYURETHANES | BAYER AKTIENGESELLSCHAFT (DT) | 1977-02-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080139806-A1 | TRIAMINOPHOSPHINE LIGANDS FOR CARBON-NITROGEN AND CARBON-CARBON BOND FORMATION | ABL1, AOC1, NPPA | CYP2D6 2326/4885KCNH2 1485/4885CHRM2 2946/4885 |
| US-20060287544-A1 | Nucleophilic heterocyclic carbene derivatives of Pd(acac)2 for cross-coupling reactions | NDC1, DDC, PDCD1LG2 | CYP2D6 1790/4885KCNH2 1130/4885CHRM2 2739/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.